— Know what they know.
Not Investment Advice
Also trades as: 4563.T (JPX) · $vol 0M

AMGXF OTC

AnGes, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -82.2% 5Y: -97.2%
$0.36
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $142.5M mcap · 387M float · 0.0001% daily turnover

Income Trends

Revenue
$875M +35.9% ▲
5Y CAGR: +85.3%
Gross Profit
$321M +29.5% ▲
5Y CAGR: +80.0%
Operating Income
-$5.1B +43.5% ▲
Net Income
-$5.1B +81.8% ▲
EPS (Diluted)
$-14.45 +88.6% ▲
EBITDA
-$5.1B +11.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$64M$67M$153M$644M$875M
YoY Growth+60.4%+4.5%+128.1%+320.7%+35.9%
Cost of Revenue$57M$3.0B$134M$396M$554M
Gross Profit$7M-$2.9B$19M$248M$321M
Gross Margin11.6%-4354.7%12.7%38.5%36.7%
R&D Expenses$10.8B$11.0B$6.2B$3.8B$3.6B
SG&A Expenses$4.9B$2.1B$5.8B$5.6B$1.9B
Operating Expenses$15.6B$13.4B$12.0B$9.4B$5.5B
Operating Income-$15.6B-$16.3B-$12.0B-$9.1B-$5.1B
Operating Margin-24369.2%-24331.3%-7822.7%-1415.3%-588.6%
Interest Expense$0$0$12M$58M$0
Income Before Tax-$13.7B-$14.7B-$7.5B-$27.6B-$5.2B
Tax Expense-$60M-$2M-$34M$485M-$113M
Net Income-$13.7B-$14.7B-$7.4B-$28.1B-$5.1B
Net Margin-21319.1%-21942.4%-4861.7%-4370.3%-586.1%
EPS (Diluted)$-92.86$-94.29$-39.29$-126.54$-14.45
EBITDA-$13.2B-$13.4B-$8.9B-$5.7B-$5.1B
Shares Outstanding147M156M189M222M355M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms